BRCA1基因启动子区域CpG岛高甲基化预示着对聚（二磷酸腺苷-核糖）聚合酶抑制剂敏感。 - Suppr

BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors.

作者信息

Veeck Jurgen, Ropero Santiago, Setien Fernando, Gonzalez-Suarez Eva, Osorio Ana, Benitez Javier, Herman James G, Esteller Manel

出版信息

J Clin Oncol. 2010 Oct 10;28(29):e563-4; author reply e565-6. doi: 10.1200/JCO.2010.30.1010. Epub 2010 Aug 2.

DOI:10.1200/JCO.2010.30.1010

PMID:20679605

Abstract

摘要

相似文献

BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors.

J Clin Oncol. 2010 Oct 10;28(29):e563-4; author reply e565-6. doi: 10.1200/JCO.2010.30.1010. Epub 2010 Aug 2.

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

Lancet Oncol. 2011 Sep;12(9):852-61. doi: 10.1016/S1470-2045(11)70214-5. Epub 2011 Aug 19.

PARP inhibitors: targeting the right patients.

J Natl Cancer Inst. 2012 Dec 19;104(24):1851-2. doi: 10.1093/jnci/djs514. Epub 2012 Dec 10.

Olaparib (Lynparza) for advanced ovarian cancer.

Med Lett Drugs Ther. 2016 Feb 29;58(1489):e32-3.

[Hereditary ovarian carcinomas: clinico-biological features and treatment].

Bull Cancer. 2014 Feb;101(2):167-74. doi: 10.1684/bdc.2014.1888.

BRCA1/2 testing: therapeutic implications for breast cancer management.

Br J Cancer. 2018 Jul;119(2):141-152. doi: 10.1038/s41416-018-0127-5. Epub 2018 Jun 5.

Olaparib, a new hope for ovarian cancer.

Indian J Cancer. 2020 Jul-Sep;57(3):346-347. doi: 10.4103/ijc.IJC_1_19.

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

Lancet. 2010 Jul 24;376(9737):245-51. doi: 10.1016/S0140-6736(10)60893-8. Epub 2010 Jul 6.

The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.

Clin Adv Hematol Oncol. 2018 May;16(5):330-332.

Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated.

Oncology (Williston Park). 2019 Jul 15;33(7):629388.

引用本文的文献

BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study.

Clin Epigenetics. 2025 Aug 7;17(1):140. doi: 10.1186/s13148-025-01917-w.

Cancer-Type-Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells.

Cancer Sci. 2025 Jul;116(7):2020-2031. doi: 10.1111/cas.70092. Epub 2025 May 2.

Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases.

Funct Integr Genomics. 2025 Mar 1;25(1):50. doi: 10.1007/s10142-025-01552-x.

BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.

Clin Epigenetics. 2024 Dec 6;16(1):178. doi: 10.1186/s13148-024-01787-8.

BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors.

Breast Cancer Res Treat. 2025 Jan;209(2):389-396. doi: 10.1007/s10549-024-07502-8. Epub 2024 Oct 11.

DNA methylation in human diseases.

Heliyon. 2024 Jun 4;10(11):e32366. doi: 10.1016/j.heliyon.2024.e32366. eCollection 2024 Jun 15.

Epigenetic editing of promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells.

Epigenetics. 2024 Dec;19(1):2357518. doi: 10.1080/15592294.2024.2357518. Epub 2024 May 26.

epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data.

Gigascience. 2022 Dec 28;12. doi: 10.1093/gigascience/giad087. Epub 2023 Oct 31.

Front Oncol. 2023 Oct 3;13:1268127. doi: 10.3389/fonc.2023.1268127. eCollection 2023.

Omics Technologies Improving Breast Cancer Research and Diagnostics.

Int J Mol Sci. 2023 Aug 11;24(16):12690. doi: 10.3390/ijms241612690.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献